Related Experiment Videos
Radiopharmacokinetics and radiation dose from 99mTc-HM-PAO (preliminary report).
H Deckart1, S Ertl, A Blottner
1Klinikum Berlin-Buch (GDR), Nuclear Medicine Clinic, DDR, Berlin.
European Journal of Nuclear Medicine
|January 1, 1987
Summary
Whole body retention of 99mTc-HM-PAO was measured in volunteers. Absorbed doses to organs were calculated using human and animal data, revealing higher brain doses from human measurements.
Area of Science:
- Nuclear Medicine
- Medical Physics
- Radiopharmacology
Background:
- Accurate absorbed dose estimation is crucial for radiopharmaceuticals.
- 99mTc-HM-PAO (Ceretec) is used for brain imaging.
- Understanding radiation dosimetry is essential for patient safety.
Purpose of the Study:
- To measure whole-body retention of 99mTc-HM-PAO in human volunteers.
- To calculate absorbed radiation doses to various organs.
- To compare absorbed doses derived from human and animal data.
Main Methods:
- Whole-body retention measurements in human volunteers post-intravenous injection of 99mTc-HM-PAO.
- Organ accumulation measurements in mice, extrapolated to humans using ICRP standards.
- Absorbed dose calculations utilizing the MIRD method and absorbed fractions.
Main Results:
- Direct human measurements allowed calculation of whole-body and brain retention.
- Absorbed doses to other organs were derived from animal data.
- Human-derived brain absorbed dose (10.3 microGy/MBq) was twice that from animal data; thyroid received the highest dose (24.4 microGy/MBq).
Conclusions:
- Direct human measurements provide more accurate absorbed dose estimates for organs like the brain.
- Animal data extrapolation may underestimate specific organ doses.
- Thyroid, ovaries, testes, and whole body absorbed doses were quantified for 99mTc-HM-PAO.